$2.500
-0.124 (-4.94%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Liminatus Pharma Inc (LIMN) Moving Averages Convergence Divergence (MACD) indicator is -0.29, suggesting LIMN is Strong sell.
Liminatus Pharma Inc (LIMN) 20-Day simple moving average is 2.99, while Liminatus Pharma Inc (LIMN) share price is $—, making it Sell.
Liminatus Pharma Inc (LIMN) 60-Day simple moving average is 3.80, while Liminatus Pharma Inc (LIMN) share price is $—, making it Sell.
Technical Analysis for LIMN
AI Technical LIMNAs of 2026-11-07, the technical board for Liminatus Pharma Inc (LIMN) reads strong sell: 1 indicators are flashing buy, 9 are indicating sell, and 3 are neutral. Price at $2.50 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 33.605, MACD stands at -0.293 (Sell), Stochastic %K stands at 23.899, Stochastic %D stands at 26.789 and CCI stands at -125.028 (Buy).
LIMN trades below the 60-day SMA (3.80) and below the 200-day SMA (10.22). Immediate resistance sits at Classic R1 3.23, then R2 3.66. Support sits at Classic S1 2.38, then S2 1.97.
Liminatus Pharma Inc (LIMN) Support & Resistance Level
Liminatus Pharma Inc (LIMN) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 33.605 |
| STOCHk_14_3_3 | 23.899 |
| STOCHd_14_3_3 | 26.789 |
| CCI_20 | -125.028 |
| AO_5_34 | -0.689 |
| MOM_10 | -0.400 |
| MACD_12_26_9 | -0.293 |
Liminatus Pharma Inc (LIMN) Relative Strength Index (RSI_14) is 33.605, creating a Neutral signal.
Liminatus Pharma Inc (LIMN) Stochastic %K is 23.899, creating a Neutral signal.
Liminatus Pharma Inc (LIMN) Stochastic %D is 26.789, creating a Neutral signal.
Liminatus Pharma Inc (LIMN) CCI_20 is -125.028, creating a Buy signal.
Liminatus Pharma Inc (LIMN) Awesome Oscillator (AO) is -0.689, creating a Sell signal.
Liminatus Pharma Inc (LIMN) Momentum (MOM) is -0.400, creating a Sell signal.
Liminatus Pharma Inc (LIMN) Moving Average Convergence Divergence (MACD) is -0.293, creating a Sell signal.
Liminatus Pharma Inc (LIMN) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 2.655 | Sell |
| MA_10 | 2.796 | Sell |
| MA_20 | 2.991 | Sell |
| MA_60 | 3.799 | Sell |
| MA_200 | 10.224 | Sell |
| MA_250 | 16.715 | Sell |
Liminatus Pharma Inc (LIMN) 5-Day simple moving average is 2.655, while Liminatus Pharma Inc (LIMN) share price is $, making it a Sell.
Liminatus Pharma Inc (LIMN) 10-Day simple moving average is 2.796, while Liminatus Pharma Inc (LIMN) share price is $, making it a Sell.
Liminatus Pharma Inc (LIMN) 20-Day simple moving average is 2.991, while Liminatus Pharma Inc (LIMN) share price is $, making it a Sell.
Liminatus Pharma Inc (LIMN) 60-Day simple moving average is 3.799, while Liminatus Pharma Inc (LIMN) share price is $, making it a Sell.
Liminatus Pharma Inc (LIMN) 200-Day simple moving average is 10.224, while Liminatus Pharma Inc (LIMN) share price is $, making it a Sell.
Liminatus Pharma Inc (LIMN) 250-Day simple moving average is 16.715, while Liminatus Pharma Inc (LIMN) share price is $, making it a Sell.
Related articles
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.